Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sivelestat for the Treatment of Adult Patients With Acute Respiratory Distress Syndrome Due to COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial

NCT05697016 is registered in ClinicalTrials.gov with Beijing Tiantan Hospital as lead sponsor.

NCT NCT05697016
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05697016 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sivelestat for the Treatment of Adult Patients With Acute Respiratory Distress Syndrome Due to COVID-19: A Randomized, Double-Blind, Placebo-Controlled Trial
Lead sponsor
Beijing Tiantan Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2023
Completion date
January 31, 2024
Enrollment
238 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory failure, respiratory infection virus